These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 30953275
1. The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury. Brandolini L, Grannonico M, Bianchini G, Colanardi A, Sebastiani P, Paladini A, Piroli A, Allegretti M, Varrassi G, Di Loreto S. Neurotox Res; 2019 Jul; 36(1):163-174. PubMed ID: 30953275 [Abstract] [Full Text] [Related]
2. DF3016A induces increased BDNF transcription in ischemic neuroinflammation injury. Grannonico M, Brandolini L, Varrassi G, Sebastiani P, Colanardi A, Paladini A, Piroli A, Allegretti M, Di Loreto S. Brain Res; 2020 Dec 01; 1748():147057. PubMed ID: 32898508 [Abstract] [Full Text] [Related]
3. C5aR antagonist inhibits occurrence and progression of complement C5a induced inflammatory response of microglial cells through activating p38MAPK and ERK1/2 signaling pathway. Liu Y, Xu SQ, Long WJ, Zhang XY, Lu HL. Eur Rev Med Pharmacol Sci; 2018 Nov 01; 22(22):7994-8003. PubMed ID: 30536348 [Abstract] [Full Text] [Related]
4. Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation. Tang M, Zhang K, Li Y, He QH, Li GQ, Zheng QY, Zhang KQ. Int Urol Nephrol; 2018 Aug 01; 50(8):1545-1553. PubMed ID: 29594894 [Abstract] [Full Text] [Related]
9. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure. Lei YC, Lu CL, Chen L, Ge K, Yang LL, Li W, Wu YH. World J Gastroenterol; 2016 Dec 14; 22(46):10148-10157. PubMed ID: 28028363 [Abstract] [Full Text] [Related]
11. The complement component C5a receptor mediates pain and inflammation in a postsurgical pain model. Liang DY, Li X, Shi X, Sun Y, Sahbaie P, Li WW, Clark DJ. Pain; 2012 Feb 14; 153(2):366-372. PubMed ID: 22137294 [Abstract] [Full Text] [Related]
12. Characterization of rat C5a anaphylatoxin receptor (C5aR): cloning of rat C5aR cDNA and study of C5aR expression by rat astrocytes. Sayah S, Patte C, Gasque P, Chan P, Ischenko A, Vaudry H, Fontaine M. Brain Res Mol Brain Res; 1997 Sep 14; 48(2):215-22. PubMed ID: 9332718 [Abstract] [Full Text] [Related]
13. Complement C5a is detrimental to histological and functional locomotor recovery after spinal cord injury in mice. Li L, Xiong ZY, Qian ZM, Zhao TZ, Feng H, Hu S, Hu R, Ke Y, Lin J. Neurobiol Dis; 2014 Jun 14; 66():74-82. PubMed ID: 24607885 [Abstract] [Full Text] [Related]
14. Complement inhibition and statins prevent fetal brain cortical abnormalities in a mouse model of preterm birth. Pedroni SM, Gonzalez JM, Wade J, Jansen MA, Serio A, Marshall I, Lennen RJ, Girardi G. Biochim Biophys Acta; 2014 Jan 14; 1842(1):107-15. PubMed ID: 24184716 [Abstract] [Full Text] [Related]
19. Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88). Nitta H, Wada Y, Kawano Y, Murakami Y, Irie A, Taniguchi K, Kikuchi K, Yamada G, Suzuki K, Honda J, Wilson-Morifuji M, Araki N, Eto M, Baba H, Imamura T. Clin Cancer Res; 2013 Apr 15; 19(8):2004-13. PubMed ID: 23287562 [Abstract] [Full Text] [Related]